Metformin monotherapy versus dual therapy with metformin and a dipeptidyl peptidase-IV inhibitor for treatment of type 2 diabetes mellitus: a systematic review and meta-analysis

被引：0
|
作者：
Tobin-Schnittger, P. [1 ]
Ong, G. [2 ]
O'Brien, T. [2 ,4 ]
Liew, A. [2 ,3 ,4 ]
机构：
[1] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland
[2] Galway Univ Hosp, Galway, Ireland
[3] Portiuncula Univ Hosp, Ballinasloe, Ireland
[4] Natl Univ Ireland Galway, Galway, Ireland
来源：
IRISH JOURNAL OF MEDICAL SCIENCE | 2016年 / 185卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P75
引用
收藏
页码：397 / 397
页数：1
相关论文
共 50 条
  • [1] Efficacy and safety of initial combined therapy with metformin plus a dipeptidyl peptidase-4 inhibitor versus metformin monotherapy in type 2 diabetes mellitus: a systematic review and meta-analysis of phase 3 randomised controlled trials
    Tangney, N.
    De Buitleir, C.
    O'Brien, T.
    Liew, A.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 : S248 - S248
  • [2] Alogliptin - A dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Glode, Ashley
    Abdelghany, Sam
    FORMULARY, 2008, 43 (09) : 317 - +
  • [3] Vildagliptin - A dipeptidyl peptidase-IV inhibitor for the treatment of type 2 diabetes
    Schlesselman, Lauren S.
    FORMULARY, 2006, 41 (10) : 494 - +
  • [4] Efficacy and safety of dipeptidyl peptidase-4 inhibitors and metformin as initial combination therapy and as monotherapy in patients with type 2 diabetes mellitus: a meta-analysis
    Wu, D.
    Li, L.
    Liu, C.
    DIABETES OBESITY & METABOLISM, 2014, 16 (01): : 30 - 37
  • [5] Weekly Versus Daily Dipeptidyl Peptidase 4 Inhibitor Therapy for Type 2 Diabetes: Systematic Review and Meta-analysis
    Yamada, Tomohide
    Shojima, Nobuhiro
    Noma, Hisashi
    Yamauchi, Toshimasa
    Kadowaki, Takashi
    DIABETES CARE, 2018, 41 (04) : E52 - E55
  • [6] Efficacy and safety of combination therapy with vildagliptin and metformin vs, metformin monotherapy for Type 2 Diabetes Mellitus therapy: a meta-analysis
    Ding, Y.
    Liu, Y.
    Qu, Y.
    Lin, M.
    Dong, F.
    Li, Y.
    Cao, L.
    Lin, S.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (08) : 2802 - 2817
  • [7] Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes A Systematic Review and Meta-analysis
    Maruthur, Nisa M.
    Tseng, Eva
    Hutfless, Susan
    Wilson, Lisa M.
    Suarez-Cuervo, Catalina
    Berger, Zackary
    Chu, Yue
    Iyoha, Emmanuel
    Segal, Jodi B.
    Bolen, Shari
    ANNALS OF INTERNAL MEDICINE, 2016, 164 (11) : 740 - +
  • [8] Metformin inhibits dipeptidyl peptidase IV activity in type 2 diabetes
    J. R. Lindsay
    N. Duffy
    A. M. McKillop
    J. Ardill
    F. P. M. O’Harte
    P. R. Flatt
    P. M. Bell
    Irish Journal of Medical Science, 2002, 171 (Suppl 5) : 29 - 29
  • [9] Metformin versus glyburide in treatment and control of gestational diabetes mellitus: a systematic review with meta-analysis
    de Oliveira, Marina Martins
    de Oliveira Andrade, Kayan Felipe
    Silva Lima, Giovanni Henrique
    Rocha, Thiago Casali
    EINSTEIN-SAO PAULO, 2022, 20 : eRW6155
  • [10] Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis
    Foroutan, Naghmeh
    Muratov, Sergei
    Levine, Mitchell
    CLINICAL AND INVESTIGATIVE MEDICINE, 2016, 39 (02): : E48 - E62
12345